Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Embrace2
Seer Medical receives FDA 510(k) for its at-home epilepsy diagnosis aide
By
Jessica Hagen
|
04:48 pm |
September 26, 2022
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
Seizure-detecting wearable Embrace2 cleared by FDA for use by children
By
Jonah Comstock
|
04:11 pm |
January 11, 2019
The clearance is a first for the relatively underserved epilepsy wearable space.